Company Listing
 
 

 

Healthcare

 

Alpha Biologics Sdn. Bhd.
PO Box 66, Pulau Tikus PO
10350 Pulau Tikus
Penang
Malaysia

Tel : +604 898 2722
Fax : +604 898 2722
http://www.alphabiologics.com

Contact:
Mr. Simon Saxby
Chief Executive Officer
Simon.Saxby@alphabiologics.com

Alpha Biologics Sdn. Bhd. is a Malaysia-based cGMP contract manufacturer of biologics drugs for use in pre-clinical, Phase 1 and Phase 2 clinical trials worldwide.

The company specializes in process development, production and purification of mammalian cell secreted protein drugs,providing the services required to deliver clients’ drugs in full compliance with cGMP guidelines.

Ample Effect Sdn. Bhd.
63A, Jalan Mega 1A
Taman Industri Mega
43500 Semenyih
Selangor
Malaysia

Tel : +603 8724 2911
Fax : +603 8724 2910
http://www.ampleeffect.com

Contact:
Mr. Victor K.C. Hiew
Chief Executive Officer
info@ampleeffect.com

Ample Effect is a Malaysia-based skincare and healthcare manufacturer that has attained Good Manufacturer Practice (GMP) status. The company’s products range from cosmetics, fragrance, internal beauty, health foods, traditional herbs to Chitosan.

Asiaprise Biotech Sdn. Bhd.
Unit 50-07-02, 2nd Floor
Wisma UOA Damansara
50 Jalan Dungun
Damansara Heights
50490 Kuala Lumpur
Malaysia

Tel : +603 2092 1088
Fax : +603 2096 2066
http://www.asiaprise.com

Contact:
Ms. Angie Ang
Corporate Consultant
ang.angie@gmail.com

Asiaprise Biotech is a wholly-owned subsidiary
of TH Group Berhad. Asiaprise Biotech owns and operates the NCI Cancer Hospital (focused on both cancer treatment and clinical research) in Nilai, Seremban with investments and shareholding in the following companies: Progenix Research Sdn. Bhd. (a contract research organization in pre-clinical trials and toxicology testing), Alpha Biologics Sdn. Bhd. (a contract
manufacturing organization for pre-clinical and clinical products for trials), MEC Dynamics Corp, US (an innovator in point-of-care diagnostic tools for the global diabetic population), Marksans Pharma Ltd., India (an established pharmaceutical company in India), and Asiaprise Pharma Sdn. Bhd. (a pharmaceutical distribution company).

Autoimmune Sdn. Bhd.
67-M, Jalan Setiabakti
Bukit Damansara
50490 Kuala Lumpur
Malaysia

Tel : +603 2092 3808
Fax : +603 2093 4808
http://www.autoimmune.com.my

 

Contact:
Mr. Patriek Yeoh
Managing Director
info@autoimmune.com.my

Involved in research, discovery, development
and commercialization of novel natural
products and lead water extracts (utilizing its proprietary Water Form Process technology platform) for pharmaceutical use to prevent and treat diseases affecting humans and animals.

Bio-Collagen Technologies Sdn. Bhd.
22-2 Jalan Kohil Hilir
Off Jalan Ipoh
51100 Kuala Lumpur
Malaysia
Tel : +603 4041 2691
Fax : +603 4042 2859

Contact:
Ms. Usha Rajasingam
Director
nakira@pl.jaring.my

The company deals with technology licensing for the production of bio-collagen/fibrogel sheets, sponge and particles from bovine sources Achilles tendons and blood).

BioSynTech Sdn. Bhd.
WISMA BST
No.23, Jalan U1/19
HICOM Glenmarie Industrial Park
40150 Shah Alam
Selangor
Malaysia

Tel : +603 5569 5112
Fax : +603 5569 5686
http://www.bst-asia.com

Contact:
Ms. Rozana Liza Fauzi
Chief Operating Officer
info@bst-asia.com
rozana@bst-asia.com

Focused on the distribution, marketing and sales of life science products and services, offering high-end instrumentations, consumables and custom services.

Bioven Sdn. Bhd.
B-13-D2, Plaza Mont Kiara
No. 2, Jalan Kiara
50480 Kuala Lumpur
Malaysia

Tel : +603 6411 8338
Fax : +603 6411 8002
http://www.bioven.com.my

Contact:
Dr. W. Shermal Perera
Chief Executive Officer
shermal@bioven.com.my

Established on 15 May 2002, Bioven Sdn. Bhd. (hereinafter referred to as Bioven) is an advanced biotechnology and life sciences

 

company which leverages on biotechnology expertise and know-how to commercialize state-of-the-art technologies and commerciallyviable health care products into the South East Asian (SEA) and the Organization of Islamic Countries (OIC) markets.

To date, Bioven has established strategic alliances with five Cuban international research institutions and their respective commercialization arms wherein specific healthcare products, technologies and research projects have been identified based on their commercial potential. In addition, business partnerships with these research institutions will elevate Bioven’s image internationally and provide a gateway for Malaysia into the rapidly developing global bio-technology industry and market.

Bioven is concentrating on a 2-pronged strategy to establish itself as a driving force in the Malaysian biotechnology industry. The first is to bring available products into the country either as alternatives to already existing ones or as novelties. The second, a long-term plan, is to bring in technologies (or projects) that will directly and indirectly benefit the biotechnology sector in the country.

With the help of selected local distributors, Bioven is currently in the process of registering various products with the relevant authorities. The product ranges from pharmaceuticals to agricultural. Bioven is also actively looking for local partners, either for distribution of products or R&D on specific projects.

DNA PRO Sdn. Bhd.
62A, Jalan SS21/62
Damansara Utama
47400 Petaling Jaya
Selangor
Malaysia

Tel : +603 7725 9218
Fax : +603 7726 8218
http://www.dnapro.biz

Contact:
Dr. Halim bin Hamat
Managing Director
dnaprohh@tm.net.my

DNA PRO is a Malaysian company engaged in manufacturing and trading biopharmaceutical products. These include hepatitis B vaccine (recombinant), stem cells, cell therapy, as well as anti-cancer and anti-AIDS vaccines.

Duopharma (M) Sdn. Bhd.
(A wholly-owned subsidiary
of Duopharma Biotech Bhd.)
Lot 2599, Jalan Seruling 59
Kawasan 3
Taman Klang Jaya
41200 Klang
Selangor
Malaysia

Tel : +603 3323 2759
Fax : +603 3323 3923/3323 1566
http://www.duopharma.com.my

Contact:
Dato’ Hj. Mizanur Rahman Ghani
Managing Director
mrg@duopharma.com.my

 

Duopharma (M) Sdn. Bhd. was formed in 1979 and Duopharma Biotech Bhd. was incorporated in August 2000 as an investment holding company for the purpose of acquiring the entire share capital of Duopharma (M) Sdn. Bhd. The
company was listed on the Second Board of Bursa Saham Malaysia Berhad on 18 July 2002 and was subsequently transferred to Main Board on 3 Nov 2003

Duopharma (M) Sdn. Bhd. manufactures more
than 300 items for consumption in Malaysia and for export. Since its venture into manufacturing, Duopharma has managed to carve a niche in the small volume injectable items as well as positioned itself as a cost leader in generic medicines.

In 1995, Duopharma upgraded its
manufacturing facilities and moved to the
89,000 sq ft factory in Klang, Malaysia. The
factory is GMP-certified. Presently, a second
state-of-the-art factory with 90,000 sq ft
area has been built based on original and
advanced production techniques to meet the
regulatory requirements of the Pharmaceutical
Inspection Co-operation Scheme, European
Commission and National Pharmaceutical
Control Bureau. The second factory is to
cater to production of small volume and
biotech injectables.

DXN Holdings Berhad
Wisma DXN
213 Lebuhraya Sultan Abdul Halim
05400 Alor Setar
Kedah
Malaysia

Tel : +604 772 3388
Fax : +604 772 1188
http://www.dxnmalaysia.com

Contact:
Mr. Lim Boon Yee
Managing Director
bylim@dxn2u.com

DXN was founded and established by Dato’ Dr. Lim Siow Jin, a graduate from the famed Indian Institute of Technology. The company was listed on the Main Board of Bursa Saham Malaysia Berhad on 30 September 2003.

The core business of DXN is the research and development of health supplements through biotechnology. To date, it has developed a number of products such as Reishi Gano and Ganocelium, Lingzhi Coffee, Tea, Body Foam, Shampoo, Edible Fungi and Fruit Juice.

DXN has taken a step further by expanding its manufacturing and marketing activities to China. Daxen Biotechnology Pte. Ltd., 100% subsidiary of DXN Holdings Bhd., was established in Gu Tian, Fujian Province on 8 December 2004. Currently, Daxen Biotechnology Pte. Ltd. has obtained an official license to conduct bio-technologyresearch and development, the import and technology, the fine processing of the Monascus, vinegar and edible fungi and the marketing of products such as Lingzhi coffee, tea, fruit juice and other drinks, as well as daily products such as toothpaste, massage oil, soap, body talc, tea tree cream and cosmetics.

 

GE Healthcare Bio-Sciences Ltd.
13, Jalan USJ 9/5P
47620 UEP Subang Jaya
Selangor
Malaysia

Tel : +603 8024 2080
Fax : +603 8024 2090
http://www.gehealthcare.com

Contact:
Ms. Phang Mee Kheng
Area Manager
mee-kheng.pang@ge.com

Offers solutions for genomic, proteomic, bioassay, preclinical imaging as well as chromatography research and production. Other products and services include education series, validation support, technology transfer programs and service contracts.

GENERTI™ Biosystems Sdn. Bhd.
44-2, Jalan Telawi
Bangsar Baru
59100 Kuala Lumpur
Malaysia

Tel : +603 2283 5811
Fax : +603 2284 2535
http://www.infovalley.net.my
Contact:
Dr. Prashanth G. Bagali
VP, Science & Technology
pgbagali@infovalley.net.my

GENERTI™ Biosystems Sdn. Bhd. is a subsidiary of INFOVALLEY™ Sdn. Bhd. The company is powered by INFOHaem™ Database, a proprietary molecular database of GENERTI on diseases expressed in blood.

Leveraging on its parent company’s ioinformatics platform technologies, GENERTI™ fabricatesmolecular diagnostics kits using an insilico approach and validates with partners in the medical institutes.

GENERTI plans to manufacture its own diagnostics kit for FH, however it also provides services by extending its insilico platform technologies for design and development of molecular diagnostics kits.

Hi-City Bioscience
Group Berhad
Plot 22, Lorong Perusahaan Maju 2
Prai Industrial Estate
Phase 4, 13600 Prai
Penang
Malaysia

Tel : +604 507 2057
Fax : +604 507 5686
http://www.hi-city.com


Contact:
Mr. Wong Chee Leong
General Manager (Corporate Affairs)
wongcl398@hotmail.com

Hi-City Bioscience Group Berhad is an investment holding company, while its wholly-owned subsidiary companies are principally involved in the manufacturing and trading of personal care, healthcare and pharmaceutical products. The Hi-City group also manufactures and trades in a comprehensive range of skincare and beauty enhancement products.

IGENE™ Sdn. Bhd.
44-2, Jalan Telawi
Bangsar Baru
59100 Kuala Lumpur
Malaysia

Tel : +603 2283 5811
Fax : +603 2284 2535
http://www.infovalley.net.my


Contact:
Dr. Pramod G. Bagali
Head of Biomedical Informatics
pramod_bagali@infovalley.net.my

iGENE™ Sdn. Bhd. is a subsidiary of INFOVALLEY™ Sdn. Bhd. The company has successfully designed and developed the world’s first commercially available software application for both forensic and pathological autopsy.

This software is supported by the SGI highperformance computing environment and Siemens Multi Slice Computerized Tomography.

iGENE™ provides solutions and services
complete with its SOPs accredited by
National Religious Council for religionsensitive markets.

 

 

 

Inno Biologics Sdn. Bhd.
W303, 3rd Floor, Block 2200
Enterprise Building 3
Persiaran APEC
63000 Cyberjaya
Malaysia

Tel : +603 8318 5288
Fax : +603 8318 2600
http://www.innobiologics.com

Contact:
Dr. Mohd Nazlee Kamal
Chief Executive Officer
nazlee.kamal@innobiologics.com

A subsidiary of Inno Bio Ventures Sdn. Bhd., Inno Biologics operates a cGMP manufacturing facility for the production of Biopharmaceuticals. Services encompass a full range production of biopharmaceutical and monoclonal antibodies based on mammalian cell culture.

The company specializes in CHO Cell
Expression System (CCES) and provides

 

InQPharm Sdn. Bhd.
E-11-07, Plaza Mont Kiara
2, Jalan Kiara
50480 Kuala Lumpur
Malaysia
Tel : +603 6201 9690
Fax : +603 6201 0690
http://www.inqpharm.com

Contact:
Dr. Carin Beumer
Chief Financial Officer
cbeumer@inqpharm.com

InQPharm is an innovative biopharmaceutical
company, specializing in the research, evelopment and commercialization of novel biological therapeutic compounds for pharmaceutical, nutritional and animal health use.

INS Bioscience Berhad
No. 62, Jalan Puteri 2/2
Bandar Puteri
47100 Puchong
Selangor
Malaysia

Tel : +603 8068 1699
Fax : +603 8061 5591
http://www.insbioscience.com

Contact:
Mr. Wong Kin Nam
Global Business Director
gbd@insbioscience.com

INS Bioscience Berhad (INSBio), part of the
INS Group, is mainly involved in the scientific research and development, manufacturing, marketing and distribution of a wide range of bioscience products, focusing on healthcare products and food supplement products.

The company leverages its entire process
value chain from seed-to-shelf: from R&D,
cultivation of raw materials, processing,
manufacturing to the commercialization of
its own brand name products, as well as
distribution of OEM products both locally
and overseas to countries in the ASEAN
region, China, Europe, Australia, New
Zealand, South Africa, Hong Kong and the
United States.

INS Bioscience is ISO 9001 certified, has
gained international recognition such as the Enterprise 50 Award, in compliance with
Good Manufacturing Practice (GMP)
standard and was recorded in the
Malaysian Book of Records as the largest
wheatgrass tea producer in Malaysia and
has won numerous medals at the International Invention Awards in Geneva and Hong Kong.

INS Bioscience’s strategic R&D alliances in health food supplements and functional food are with leading companies and institutions. Among them are Universiti Putra Malaysia (UPM), the leading Center of excellence for agriculture studies; China Bioway Biotech Group Co. Ltd., the largest biotech group in China; and China Agricultural University, the top research university in China for functional food.

 

KL Biotech Sdn. Bhd.
No. 59, Jalan Gasing
46000 Petaling Jaya
Selangor
Malaysia

Tel : +603 7955 6478
Fax : +603 7958 4109
http://www.klbiotech.com

Contact:
Dr. Abdul Reezal
Chief Executive Officer
reezal@klbiotech.com

Involved in the R&D commercialization of active ingredients from local biodiversity.

Magna Mission Sdn. Bhd.
29-1 & 2, Plaza Crystal Ville 1
Jalan 22A/ 70A
Desa Sri Hartamas
50480 Kuala Lumpur
Malaysia

Tel : +603 6203 2863
Fax : +603 6203 2864
http://www.diabegard.com

Contact:
Mr. Subramaniam A/L Supparoo
Managing Director
info@diabegard.com

Magna Mission Sdn. Bhd. is a wholly owned Malaysian company incorporated on 1 August 2000. It is a biotechnology driven company dedicated to promoting better health worldwide through its product, Diabegard, a herbal medicine and daily supplement which is safe and well tolerated. It contains the biotechnological breakthrough, polypeptide-k, a plant protein, which is referred to as “plant insulin.” It is patented in 93 countries, including the US and Japan.

Malaysian Bio-Diagnostics
Research Sdn. Bhd.
Block Intron-Ekson UKM-MTDC
Smart Technology Center
43650 Bangi
Selangor
Malaysia

Tel : +603 8926 1205
Fax : +603 8926 1810
http://www.mbdr.net

Contact:
En. Emeri Johari
Chief Executive Officer
emeri@mbdr.net

Malaysian Bio-Diagnostics Research Sdn. Bhd. (MBDr) was incorporated in 1994 and began operations in September 1995. Initially established to commercialize research undertaken on diagnostics of typhoid ever,MBDr has expanded into producing other medical diagnostics products that include pregnancy tests, drugs of abuse tests and brugian filariasis.

 

Malaysian Vaccines and Pharmaceuticals Sdn. Bhd.
Block Grana
UKM-MTDC Smart Technology Center
43600 Bangi
Selangor
Malaysia

Tel : +603 8922 3508
Fax : +603 8922 3503
http://www.mvp.com.my

Contact:
Dr. Roshidah Ismail
Operations Manager
mvp@tm.net.my

Established in 1992, it is the first veterinary vaccine manufacturing company in Malaysia. The company has undertaken the privatization of the production of animal vaccines from the Veterinary Research Institute, Malaysian Department of Veterinary Services since 1992.

Presently, the company produces vaccines mainly for poultry and swine diseases, like Infectious Bursal Disease Vaccine. This lyophilized vaccine contains adapted embryo and is highly immunogenic. It carries the intermediate hot V877 strain of IBD virus and is propagated in SPF eggs. It is used for active immunization of chickens against Infectious Bursal Disease between 10 and 14 days of age.

Phytes Biotek Sdn. Bhd.
Lot 21, Jalan U1/19 Section U1
Hicom-Glenmarie Industrial Park
40150 Shah Alam
Selangor
Malaysia

Tel : +603 5569 1100
Fax : +603 5569 1177

Contact:
Dr. Azizol Abdul Kadir
Chief Executive Officer
drazizol@yahoo.com

Manufactures standardized herbal extracts and finished products.

Phytofolia Sdn. Bhd.

29A, Jalan Pulai Perdana 11
Taman Sri Pulai Perdana
81100 Skudai
Johor
Malaysia

Tel : +607 552 0599
Fax : +607 551 7082

Contact:
En. Ab. Hamid Baskar
Director, Business Development & Marketing
phyfolia@tm.net.my

Involved in the processed Virgin Coconut Oil (VCO) and “Mas Cotek”.

Progenix Research Sdn. Bhd.
Lion Court
Ashby de la Zouch
Leicestershire
LE65 1RT
United Kingdom

Tel : +44 1332 695010
Fax : +44 1332 695001
http://www.progenixresearch.com

Contact:
Dr. James Cockrill
Chief Executive Officer
info@progenixresearch.com

Progenix Research Sdn Bhd is a newly formed, independent contract research organisation with laboratory facilities currently under construction in Penang, Malaysia. A high quality, yet cost-efficient service for toxicology and associated studies will be offered world-wide - including studies on pharmaceuticals, biotechnology products, medical devices, food additives, agrochemicals, biocides, and speciality chemicals.

 

StemLife Sdn. Bhd.
B-7-15 Megan Avenue II
12 Jalan Yap Kwan Seng
50450 Kuala Lumpur
Malaysia

Tel : +603 2163 8800
Fax : +603 2164 9808
http://www.stemlife.com

Contact:
Ms. Sharon Low
Managing Director
sl@stemlife.com

StemLife is Malaysia’s first stem cell bank
and regenerative medicine company.
Established and managed by leading
medical specialists and professionals in 2001, StemLife was awarded the prestigious MSC status and Pioneer Tax Status by the Ministry of Trade and Industry.

StemLife is a significant contributor to the
training of graduates in the Health Science
Industry, and has strategic collaborations
with medical institutions for research in
stem cell expansion and therapy.

StemLife is the largest cord blood and adult stem cell bank in South East Asia and has provided stem cells for patients with cancer, thalassemia, heart disorders and diabetic ulcer treatment.

TMC Life Sciences Berhad
No. 55, Jalan SS21/56B
Damansara Utama
47400 Petaling Jaya
Selangor
Malaysia

Tel : +603 7729 3199
Fax : +603 7727 8066
http://www.damansarafertility.com

Contact:
Dr. Colin Lee
Managing Director
colinleess@damansarafertility.com

TMC Life Sciences Berhad, listed on
MESDAQ on 6 October 2005, is the
investment holding company of Damansara Women’s Specialist Center Sdn. Bhd., Damansara Fertility Center Sdn. Bhd. and IVF Technologies Sdn. Bhd.. As a one-stop healthcare facility for women, the Group provides fertility services and general O&G services. The Group is one of the very few centers to provide a comprehensive range of fertility services in the region today. The Group believes it is a market leader in Assisted Reproductive Technologies (ART), accounting for about one-third of all testtube babies produced in Malaysia. Its IVF clinical pregnancy success rate of 54.3% is comparable to those of top IVF centers in the UK and US. IVF Technologies Sdn. Bhd. is the R&D arm of TMC Life Sciences Berhad and has successfully developed a mathematic equation to determine the number of holes to be drilled to optimize the success in ovarian drilling procedures as well as other ART result-enhancing techniques.
The group has four centers located in
Damansara Utama, Petaling Jaya, Selangor; Kepong, Kuala Lumpur; Johor Bahru, Johor; and Sibu, Sarawak.

Zontron Pharmaceuticals Sdn. Bhd.
Lot 10 & 11, Perda Industrial Park
Lorong IKS, Simpang Ampat B
Simpang Ampat
14100 Pulau Pinang
Malaysia

Tel : +604 588 0519
Fax : +604 588 0424

Contact:
Mr. Vispanathan Ainiman
Managing Director
zontron@pd.jaring.my

A Malaysian company involved in the manufacturing of pharmaceutical products in dosage forms, R&D and bioequivalent studies. It has 75 employees, 15 of which are involved in biotechnology activities.

 

<<back